119 related articles for article (PubMed ID: 34586268)
1. [International capital companies and the Brazilian health system: a study on renal replacement therapy].
Pescuma Junior A; Alves DFA; Mendes A; Bousquat A
Cien Saude Colet; 2021 Sep; 26(9):4163-4172. PubMed ID: 34586268
[TBL] [Abstract][Full Text] [Related]
2. [The entry of foreign capital into the health system in Brazil].
Scheffer M; Souza PMS
Cad Saude Publica; 2022; 38Suppl 2(Suppl 2):e00239421. PubMed ID: 36043629
[TBL] [Abstract][Full Text] [Related]
3. Hurdles in tissue engineering/regenerative medicine product commercialization: a pilot survey of governmental funding agencies and the financial industry.
Bertram TA; Tentoff E; Johnson PC; Tawil B; Van Dyke M; Hellman KB
Tissue Eng Part A; 2012 Nov; 18(21-22):2187-94. PubMed ID: 22838399
[TBL] [Abstract][Full Text] [Related]
4. [Foreign capital and structural change in the Brazilian private health services market].
Kamia FD; Vargas MA
Cad Saude Publica; 2023; 39(9):e00171222. PubMed ID: 37792818
[TBL] [Abstract][Full Text] [Related]
5. [Financialization, accumulation, and shareholding changes in companies and corporate groups in the Brazilian health sector].
Mattos LV; Carvalho EMCL; Barbosa DVS; Bahia L
Cad Saude Publica; 2022; 38Suppl 2(Suppl 2):e00175820. PubMed ID: 36043625
[TBL] [Abstract][Full Text] [Related]
6. [Economic crisis and disparities in spending, supply, and use of public and private health services in Brazil from 2011 to 2019].
Costa DCAR; Moreira JPL; Cardoso AM; Mattos LV; Andrietta LS; Bahia L
Cad Saude Publica; 2022; 38(10):e00262221. PubMed ID: 36449852
[TBL] [Abstract][Full Text] [Related]
7. Funding renal replacement therapy in southeast Asia: building public-private partnerships in Singapore, Malaysia, Thailand, and Indonesia.
Morad Z; Choong HL; Tungsanga K; Suhardjono
Am J Kidney Dis; 2015 May; 65(5):799-805. PubMed ID: 25736214
[TBL] [Abstract][Full Text] [Related]
8. Private sector joins family planning effort.
Front Lines; 1989 Dec; ():6, 13. PubMed ID: 12343476
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of financial statements from companies in the Brazilian health sector (2009-2015): concentration, centralization of capital, and expressions of financialization].
Andrietta LS; Monte-Cardoso A
Cad Saude Publica; 2022; 38Suppl 2(Suppl 2):e00006020. PubMed ID: 36043616
[TBL] [Abstract][Full Text] [Related]
10. How the 'plates' of a health system can shift, change and adjust during economic recessions: A qualitative interview study of public and private health providers in Brazil's São Paulo and Maranhão states.
Russo G; Levi ML; Seabra Soares de Britto E Alves MT; Carneiro Alves de Oliveira BL; de Souza Britto Ferreira de Carvalho RH; Andrietta LS; Filippon JG; Scheffer MC
PLoS One; 2020; 15(10):e0241017. PubMed ID: 33104705
[TBL] [Abstract][Full Text] [Related]
11. Understanding the complex relationships among actors involved in the implementation of public-private mix (PPM) for TB control in India, using social theory.
Salve S; Harris K; Sheikh K; Porter JDH
Int J Equity Health; 2018 Jun; 17(1):73. PubMed ID: 29880052
[TBL] [Abstract][Full Text] [Related]
12. Brazilian private health system: history, scenarios, and trends.
Cruz JAW; da Cunha MAVC; de Moraes TP; Marques S; Tuon FF; Gomide AL; de Paula Linhares G
BMC Health Serv Res; 2022 Jan; 22(1):49. PubMed ID: 35012514
[TBL] [Abstract][Full Text] [Related]
13. [The health system of Brazil].
Montekio VB; Medina G; Aquino R
Salud Publica Mex; 2011; 53 Suppl 2():s120-31. PubMed ID: 21877078
[TBL] [Abstract][Full Text] [Related]
14. [The public-private mix in the Brazilian Health System: financing, delivery and utilization of health services].
Santos IS; Ugá MA; Porto SM
Cien Saude Colet; 2008; 13(5):1431-40. PubMed ID: 18813646
[TBL] [Abstract][Full Text] [Related]
15. End-stage renal failure and national resources: the Brazilian experience.
Zatz R; Romão JE
Ren Fail; 2006; 28(8):627-9. PubMed ID: 17162419
[TBL] [Abstract][Full Text] [Related]
16. [Capital accumulation patterns: capital and services in the current transformations of the health system].
de Andreazzi Mde F; Kornis GE
Cien Saude Colet; 2008; 13(5):1409-20. PubMed ID: 18813644
[TBL] [Abstract][Full Text] [Related]
17. The potential of health sector non-governmental organizations: policy options.
Gilson L; Sen PD; Mohammed S; Mujinja P
Health Policy Plan; 1994 Mar; 9(1):14-24. PubMed ID: 10133097
[TBL] [Abstract][Full Text] [Related]
18. From health plan companies to international insurance companies: changes in the accumulation regime and repercussions on the healthcare system in Brazil.
Bahia L; Scheffer M; Tavares LR; Braga IF
Cad Saude Publica; 2016 Nov; 32Suppl 2(Suppl 2):e00154015. PubMed ID: 27828680
[TBL] [Abstract][Full Text] [Related]
19. Brazilian healthcare in the context of austerity: private sector dominant, government sector failing.
Costa NDR
Cien Saude Colet; 2017 Apr; 22(4):1065-1074. PubMed ID: 28444034
[TBL] [Abstract][Full Text] [Related]
20. [Reflections on public-private participation in healthcare].
Carvalho RR; Fortes PA; Garrafa V
Salud Publica Mex; 2014 Apr; 56(2):221-5. PubMed ID: 25014429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
